Institutional Ownership Abbott Laboratories (ABT)
This table provides information about the institutional ownership of Abbott Laboratories (ABT). We have compiled data on the 3,655 institutions that hold shares in the stock, with a total of 1.38 Billion shares, which have been reported (via 13F filing form) to have a value of $180 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
173,154,308
shares
|
$22.5 Billion
0.36% of portfolio
|
Q3 2025
Added 0.2%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
131,129,688
shares
|
$17.1 Billion
0.31% of portfolio
|
Q2 2024
Reduced 1.46%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
78,225,991
shares
|
$10.2 Billion
0.37% of portfolio
|
Q3 2025
Reduced 0.16%
|
|
|
Capital International Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
61,614,739
shares
|
$8.01 Billion
1.4% of portfolio
|
Q3 2025
Added 2.46%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
38,768,839
shares
|
$5.04 Billion
1.02% of portfolio
|
Q3 2025
Reduced 7.18%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
38,634,796
shares
|
$5.02 Billion
0.33% of portfolio
|
Q3 2025
Added 9.74%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
38,541,894
shares
|
$5.01 Billion
0.34% of portfolio
|
Q3 2025
Added 0.65%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
29,383,217
shares
|
$3.82 Billion
0.26% of portfolio
|
Q3 2025
Reduced 26.4%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
23,246,144
shares
|
$3.02 Billion
0.57% of portfolio
|
Q3 2025
Reduced 7.2%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
20,805,826
shares
|
$2.71 Billion
0.19% of portfolio
|
Q3 2025
Reduced 4.1%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
20,442,820
shares
|
$2.66 Billion
0.36% of portfolio
|
Q3 2025
Reduced 2.84%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
17,769,095
shares
|
$2.31 Billion
1.45% of portfolio
|
Q3 2025
Added 112.38%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
16,707,340
shares
|
$2.17 Billion
0.44% of portfolio
|
Q3 2025
Reduced 2.8%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
16,128,211
shares
|
$2.1 Billion
0.28% of portfolio
|
Q3 2025
Added 6.08%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
15,800,759
shares
|
$2.05 Billion
0.23% of portfolio
|
Q3 2025
Added 52.67%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Oct 29, 2025 Q3 2025 |
15,096,907
shares
|
$1.96 Billion
0.67% of portfolio
|
Q3 2025
Added 5.75%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
13,951,907
shares
|
$1.81 Billion
0.31% of portfolio
|
Q3 2025
Added 51.01%
|
|
|
State Farm Mutual Automobile Insurance CO
Bloomington, IL |
Nov 12, 2025 Q3 2025 |
13,587,118
shares
|
$1.77 Billion
1.53% of portfolio
|
Q3 2021
Reduced 6.82%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2025 Q3 2025 |
13,500,829
shares
|
$1.76 Billion
0.44% of portfolio
|
Q3 2025
Added 3.84%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
13,137,337
shares
|
$1.71 Billion
0.29% of portfolio
|
Q3 2025
Reduced 0.3%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
12,900,318
shares
|
$1.68 Billion
0.4% of portfolio
|
Q3 2025
Added 7.18%
|
|
|
Bank Of New York Mellon Corp
New York, NY |
Nov 03, 2025 Q3 2025 |
12,678,513
shares
|
$1.65 Billion
0.0% of portfolio
|
Q3 2025
Reduced 0.47%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2025 Q3 2025 |
12,032,884
shares
|
$1.56 Billion
0.59% of portfolio
|
Q3 2025
Added 1.43%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
11,654,561
shares
|
$1.52 Billion
0.43% of portfolio
|
Q3 2025
Reduced 4.63%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
11,058,724
shares
|
$1.44 Billion
0.37% of portfolio
|
Q4 2024
Reduced 0.35%
|
|